FT  14 FEB 92 / International Company News: Pfizer slips on growth warning
SHARES in Pfizer, one of the biggest US drugs companies, tumblwed Dollars 2
5/8 to Dollars 72 5/8 yesterday in heavy trading after the company outlined
only moderate first-half profit growth at a meeting with analysts.
The company expects full-year earnings to meet analysts' expectations, but
it warned that the cost of launching new drugs would probably cut into its
first-half results.
Pfizer is scheduled to introduce its new Zoloft anti-depressant later this
month, followed by the launch of its Zithromax antibiotic in early March.
The company may launch three other new drugs by the end of the year.
